middle.news
Neuren’s trofinetide engine gains a German boost
9:57am on Thursday 5th of November, 2026 AEDT
•
Biotechnology and Pharmaceuticals
Read Story
Neuren’s trofinetide engine gains a German boost
9:57am on Thursday 5th of November, 2026 AEDT
Key Points
2026 trofinetide income guidance raised to US$91m-US$93m
Q3 DAYBUE sales rose 39% to US$140m
US$35m milestone earned on first German commercial sale
Q3 royalty income increased 51% to US$16.4m
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neuren Pharmaceuticals (ASX:NEU)
OPEN ARTICLE